Operating Lease, Right-of-Use Asset in USD of VITASPRING BIOMEDICAL CO. LTD. from Q3 2021 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Vitaspring Biomedical Co. Ltd. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2021 to Q4 2023.
  • Vitaspring Biomedical Co. Ltd. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2023 was $53.7K, a 44.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)

VITASPRING BIOMEDICAL CO. LTD. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2023 $53.7K -$42.9K -44.4% Dec 31, 2023 10-K 2025-12-01
Q4 2022 $96.6K -$363K -79% Dec 31, 2022 10-K 2025-12-01
Q3 2022 $322K -$183K -36.3% Oct 31, 2022 10-Q 2022-12-21
Q2 2022 $368K Jul 31, 2022 10-Q 2022-09-15
Q1 2022 $414K Apr 30, 2022 10-Q 2022-06-15
Q4 2021 $460K Jan 31, 2022 10-K 2025-12-01
Q3 2021 $506K Oct 31, 2021 10-Q 2021-12-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.